Pepcid Ingredient Famotidine Being Tested as COVID-19 Treatment

The patients are being given famotidine, the active ingredient in Pepcid, and early results from the trial could be available in the next few weeks.

APRIL 27, 2020 — COVID-19 individuals at some New York hospitals are acquiring heartburn drugs as component of a scientific trial.

The individuals are getting presented famotidine, the lively ingredient in Pepcid, and early outcomes from the trial could be obtainable in the future handful of months, in accordance to Dr. Kevin Tracey, president of Feinstein Institutes for Medical Analysis at Northwell Well being, which has 23 hospitals in the New York City place, CNN noted.

The scientific trial has 187 individuals so significantly, with the objective of enrolling 1,200, Tracey stated.

He and his colleagues made a decision to

Read More